Molecular Mechanisms and Therapeutic Implications of Bioactive Substances from Medicinal Plants in Type 2 Diabetes

Abstract Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, impaired insulin secretion, and systemic inflammation. Despite the availability of various pharmacological agents, current treatments often present limitations such as adverse effects and reduced long-term efficacy. Medicinal plants, long used in traditional medicine systems, offer a promising alternative due to their diverse bioactive compounds and multifaceted mechanisms of action. This review explores the molecular mechanisms and therapeutic implications of bioactive substances derived from medicinal plants in the management of T2DM. Plant-derived compounds such as flavonoids, alkaloids, terpenoids, phenolic acids, and saponins have demonstrated significant antidiabetic effects through multiple molecular pathways. These bioactive molecules enhance insulin sensitivity, stimulate insulin secretion, inhibit intestinal glucose absorption, and modulate glucose and lipid metabolism. Additionally, they exert antioxidant, anti-inflammatory, and antiapoptotic effects that contribute to the preservation of pancreatic β-cell function and overall metabolic homeostasis. Key signaling pathways affected include AMP-activated protein kinase (AMPK), phosphoinositide 3-kinase/protein kinase B (PI3K/Akt), peroxisome proliferator-activated receptors (PPARs), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). The therapeutic potential of these substances is further supported by in vitro, in vivo, and limited clinical studies that reveal beneficial glycemic outcomes and improved insulin responsiveness. However, challenges such as poor bioavailability, lack of standardization, and insufficient clinical validation hinder their integration into mainstream therapeutics. Advances in nanotechnology, pharmacokinetics, and formulation science are being explored to enhance their efficacy and stability. In conclusion, bioactive compounds from medicinal plants offer a rich source of novel antidiabetic agents with diverse molecular targets. Further research into their pharmacodynamics, toxicity profiles, and clinical effectiveness is essential to fully harness their potential as complementary or alternative therapies in T2DM management. This underscores the need for interdisciplinary approaches bridging ethnobotany, molecular biology, and pharmacology.